Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06289647
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-02-23
Brief Title:
Azithromycin Reduction to Reach Elimination of Trachoma B
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Study Overview
Official Title:
Azithromycin Reduction to Reach Elimination of Trachoma B
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARRET
Brief Summary:
The investigators propose a randomized controlled trial of discontinuation versus continuation of annual mass azithromycin distribution in hypoendemic communities of Maniema DRC The investigators will randomize communities with up to 20 Trachomatous Inflammation - Follicular TF prevalence following at least 5 years of mass azithromycin distribution to discontinuation or continuation of 3 additional years of annual mass azithromycin distribution
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5UG1EY030833 | NIH | None | httpsreporternihgovquickSearch5UG1EY030833 |